Mitsuhiro Matsuda

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

Journal: Cancer immunology, immunotherapy : CII

Published: February 14, 2024

Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Journal: International journal of hematology

Published: August 26, 2023

Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum.

Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum.

Journal: Leukemia research reports

Published: July 05, 2023

Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Journal: International journal of hematology

Published: June 25, 2023

Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum.

Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum.

Journal: International journal of hematology

Published: April 04, 2023

Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin.

Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin.

Journal: Scientific reports

Published: December 13, 2022

Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide.

Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide.

Journal: Therapeutic advances in hematology

Published: July 29, 2022

Novel prognostic predictor of haemoglobin-platelet index in diffuse large B-cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL-6 production in lymphoma cells.

Novel prognostic predictor of haemoglobin-platelet index in diffuse large B-cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL-6 production in lymphoma cells.

Journal: British journal of haematology

Published: January 31, 2022

Anti-desmoglein 1 antibody-positive mother and antibody-negative child with Darier's disease.

Anti-desmoglein 1 antibody-positive mother and antibody-negative child with Darier's disease.

Journal: The Journal of dermatology

Published: January 20, 2022

Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.

Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.

Journal: International journal of hematology

Published: December 10, 2021

Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis.

Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis.

Journal: Therapeutic advances in hematology

Published: December 01, 2021

Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.

Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.

Journal: Cancer science

Published: July 10, 2021

Showing 1-12 of 53

Last Updated: 09/26/2026